 Edward Hoffenberg
Concepts (338)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Celiac Disease | 29 | 2024 | 308 | 3.720 |
Why?
| | Crohn Disease | 11 | 2019 | 260 | 1.880 |
Why?
| | Inflammatory Bowel Diseases | 10 | 2022 | 365 | 1.740 |
Why?
| | Transglutaminases | 19 | 2024 | 159 | 1.420 |
Why?
| | Colitis, Ulcerative | 6 | 2019 | 148 | 1.410 |
Why?
| | Autoantibodies | 18 | 2024 | 1504 | 1.300 |
Why?
| | Marijuana Use | 2 | 2018 | 213 | 0.800 |
Why?
| | Medical Marijuana | 3 | 2019 | 123 | 0.670 |
Why?
| | Cannabinol | 1 | 2019 | 2 | 0.590 |
Why?
| | Anti-Inflammatory Agents | 4 | 2017 | 475 | 0.580 |
Why?
| | Mass Screening | 6 | 2024 | 1348 | 0.520 |
Why?
| | Arterio-Arterial Fistula | 1 | 2016 | 4 | 0.480 |
Why?
| | Hematemesis | 1 | 2016 | 4 | 0.470 |
Why?
| | Aneurysm, Infected | 1 | 2016 | 4 | 0.470 |
Why?
| | Dronabinol | 1 | 2019 | 247 | 0.470 |
Why?
| | Esophageal Fistula | 1 | 2016 | 21 | 0.470 |
Why?
| | Intestinal Polyps | 2 | 2013 | 14 | 0.450 |
Why?
| | Aortic Coarctation | 1 | 2016 | 79 | 0.440 |
Why?
| | Marijuana Smoking | 1 | 2018 | 250 | 0.430 |
Why?
| | Health Services Misuse | 1 | 2014 | 36 | 0.420 |
Why?
| | Aortic Diseases | 1 | 2016 | 124 | 0.420 |
Why?
| | Gastrointestinal Agents | 3 | 2017 | 66 | 0.390 |
Why?
| | Capsule Endoscopy | 2 | 2013 | 25 | 0.390 |
Why?
| | Motivation | 1 | 2018 | 610 | 0.390 |
Why?
| | Sertoli Cell Tumor | 1 | 2013 | 2 | 0.390 |
Why?
| | Peutz-Jeghers Syndrome | 1 | 2013 | 10 | 0.390 |
Why?
| | Intussusception | 1 | 2013 | 25 | 0.380 |
Why?
| | Adolescent | 31 | 2024 | 22453 | 0.380 |
Why?
| | Antibodies, Monoclonal | 4 | 2014 | 1524 | 0.380 |
Why?
| | Intestinal Mucosa | 4 | 2015 | 676 | 0.370 |
Why?
| | Short Bowel Syndrome | 3 | 2011 | 27 | 0.370 |
Why?
| | Immunosuppressive Agents | 1 | 2017 | 847 | 0.370 |
Why?
| | Child | 40 | 2024 | 22657 | 0.370 |
Why?
| | Immunoglobulin A | 8 | 2024 | 214 | 0.350 |
Why?
| | Jejunum | 1 | 2011 | 35 | 0.330 |
Why?
| | Gliadin | 2 | 2007 | 13 | 0.330 |
Why?
| | Cerebral Palsy | 1 | 2013 | 132 | 0.330 |
Why?
| | Heart Transplantation | 1 | 2017 | 736 | 0.330 |
Why?
| | Humans | 73 | 2024 | 144957 | 0.320 |
Why?
| | Gastrointestinal Tract | 1 | 2013 | 208 | 0.320 |
Why?
| | Pyloric Stenosis | 1 | 2010 | 3 | 0.320 |
Why?
| | Clinical Laboratory Techniques | 1 | 2011 | 96 | 0.310 |
Why?
| | Intestine, Small | 6 | 2013 | 166 | 0.310 |
Why?
| | Autoimmunity | 4 | 2011 | 927 | 0.310 |
Why?
| | Gastrointestinal Hemorrhage | 2 | 2009 | 136 | 0.300 |
Why?
| | Child, Preschool | 25 | 2024 | 11799 | 0.300 |
Why?
| | Jejunal Diseases | 1 | 2009 | 6 | 0.300 |
Why?
| | Ibuprofen | 1 | 2010 | 84 | 0.300 |
Why?
| | Diabetes Mellitus, Type 1 | 7 | 2017 | 3890 | 0.290 |
Why?
| | Infusions, Intravenous | 1 | 2009 | 423 | 0.280 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2017 | 1416 | 0.270 |
Why?
| | Infliximab | 4 | 2017 | 108 | 0.270 |
Why?
| | Colorado | 8 | 2024 | 4564 | 0.260 |
Why?
| | Male | 40 | 2024 | 72406 | 0.260 |
Why?
| | Delivery of Health Care | 1 | 2014 | 947 | 0.260 |
Why?
| | Wheat Hypersensitivity | 1 | 2007 | 4 | 0.260 |
Why?
| | Diet, Gluten-Free | 3 | 2024 | 56 | 0.250 |
Why?
| | Incidence | 5 | 2018 | 2883 | 0.240 |
Why?
| | Gastroenterology | 4 | 2023 | 189 | 0.240 |
Why?
| | Nutritional Support | 1 | 2006 | 39 | 0.240 |
Why?
| | Quality Improvement | 1 | 2014 | 1291 | 0.230 |
Why?
| | Enterocytes | 3 | 2003 | 16 | 0.220 |
Why?
| | Infusions, Parenteral | 1 | 2005 | 41 | 0.220 |
Why?
| | Female | 37 | 2024 | 78376 | 0.220 |
Why?
| | HLA-DQ Antigens | 3 | 2017 | 173 | 0.220 |
Why?
| | HLA-DR Antigens | 3 | 2017 | 220 | 0.210 |
Why?
| | Glutens | 5 | 2005 | 59 | 0.210 |
Why?
| | Infant | 22 | 2024 | 10039 | 0.210 |
Why?
| | Antibodies, Fungal | 2 | 2005 | 9 | 0.210 |
Why?
| | Citrulline | 1 | 2003 | 46 | 0.190 |
Why?
| | Case-Control Studies | 6 | 2019 | 3608 | 0.190 |
Why?
| | Antioxidants | 2 | 1997 | 549 | 0.190 |
Why?
| | Time Factors | 7 | 2017 | 7183 | 0.190 |
Why?
| | Genetic Predisposition to Disease | 5 | 2017 | 2365 | 0.190 |
Why?
| | Pregnancy Outcome | 1 | 2006 | 476 | 0.190 |
Why?
| | Emergency Service, Hospital | 1 | 2014 | 2313 | 0.180 |
Why?
| | Colonic Polyps | 2 | 2004 | 85 | 0.180 |
Why?
| | Severity of Illness Index | 3 | 2019 | 2925 | 0.170 |
Why?
| | Home Care Services | 1 | 2005 | 280 | 0.170 |
Why?
| | Sensitivity and Specificity | 5 | 2009 | 1990 | 0.170 |
Why?
| | Child Development | 1 | 2006 | 484 | 0.170 |
Why?
| | Follow-Up Studies | 6 | 2024 | 5417 | 0.160 |
Why?
| | Avena | 1 | 2000 | 3 | 0.160 |
Why?
| | Safety | 3 | 2017 | 356 | 0.160 |
Why?
| | Patient Satisfaction | 1 | 2005 | 705 | 0.160 |
Why?
| | Pregnancy Complications | 1 | 2006 | 592 | 0.160 |
Why?
| | Abdominal Pain | 2 | 1999 | 146 | 0.150 |
Why?
| | Ileal Diseases | 2 | 2014 | 14 | 0.150 |
Why?
| | Infant, Newborn | 10 | 2011 | 6434 | 0.150 |
Why?
| | Administration, Oral | 2 | 2019 | 848 | 0.150 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2014 | 1217 | 0.150 |
Why?
| | Predictive Value of Tests | 4 | 2007 | 2118 | 0.150 |
Why?
| | Antibodies, Antineutrophil Cytoplasmic | 1 | 1999 | 33 | 0.150 |
Why?
| | Saccharomyces cerevisiae | 2 | 2005 | 579 | 0.150 |
Why?
| | Government Regulation | 1 | 2019 | 38 | 0.140 |
Why?
| | Autoimmune Diseases | 3 | 2017 | 463 | 0.140 |
Why?
| | Aminoglycosides | 1 | 2018 | 29 | 0.140 |
Why?
| | Diarrhea | 2 | 2018 | 192 | 0.140 |
Why?
| | Surveys and Questionnaires | 4 | 2024 | 6053 | 0.140 |
Why?
| | Cannabinoids | 2 | 2017 | 182 | 0.140 |
Why?
| | Radioimmunoassay | 3 | 2005 | 165 | 0.140 |
Why?
| | Clostridium Infections | 1 | 2018 | 74 | 0.130 |
Why?
| | Urine | 1 | 2017 | 62 | 0.130 |
Why?
| | Biopsy, Needle | 2 | 2011 | 183 | 0.130 |
Why?
| | Risk Factors | 8 | 2017 | 10792 | 0.120 |
Why?
| | Prospective Studies | 6 | 2024 | 7997 | 0.120 |
Why?
| | Young Adult | 4 | 2019 | 14126 | 0.120 |
Why?
| | Legislation, Drug | 1 | 2017 | 73 | 0.120 |
Why?
| | Endocannabinoids | 1 | 2017 | 57 | 0.120 |
Why?
| | Failure to Thrive | 1 | 1996 | 28 | 0.120 |
Why?
| | Feces | 3 | 2018 | 513 | 0.120 |
Why?
| | Numismatics | 1 | 2015 | 2 | 0.120 |
Why?
| | Colonoscopy | 2 | 2017 | 261 | 0.120 |
Why?
| | Quality Assurance, Health Care | 1 | 2018 | 340 | 0.120 |
Why?
| | Rotavirus Infections | 3 | 2006 | 35 | 0.120 |
Why?
| | Case Management | 1 | 1996 | 68 | 0.120 |
Why?
| | Plasma | 1 | 2017 | 225 | 0.120 |
Why?
| | Duodenum | 4 | 2022 | 77 | 0.110 |
Why?
| | Serologic Tests | 3 | 2007 | 53 | 0.110 |
Why?
| | Alagille Syndrome | 1 | 1995 | 29 | 0.110 |
Why?
| | Retrospective Studies | 9 | 2023 | 17101 | 0.110 |
Why?
| | Quality of Health Care | 2 | 2018 | 693 | 0.110 |
Why?
| | Pneumococcal Infections | 1 | 2016 | 103 | 0.110 |
Why?
| | After-Hours Care | 1 | 2014 | 16 | 0.110 |
Why?
| | Critical Pathways | 1 | 1996 | 108 | 0.110 |
Why?
| | Biological Products | 1 | 2018 | 252 | 0.110 |
Why?
| | Foreign Bodies | 1 | 2015 | 107 | 0.110 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 4 | 2009 | 851 | 0.110 |
Why?
| | Tandem Mass Spectrometry | 1 | 2017 | 577 | 0.100 |
Why?
| | Cross-Sectional Studies | 2 | 2018 | 5872 | 0.100 |
Why?
| | Streptococcus pneumoniae | 1 | 2016 | 177 | 0.100 |
Why?
| | Gastrointestinal Diseases | 1 | 1996 | 216 | 0.100 |
Why?
| | Colitis | 1 | 2017 | 280 | 0.100 |
Why?
| | Prevalence | 3 | 2013 | 2836 | 0.100 |
Why?
| | Biopsy | 3 | 2007 | 1077 | 0.100 |
Why?
| | Rotavirus | 4 | 2006 | 20 | 0.100 |
Why?
| | Esophagus | 1 | 2015 | 261 | 0.100 |
Why?
| | Self Report | 1 | 2018 | 873 | 0.100 |
Why?
| | Telemedicine | 1 | 2023 | 948 | 0.100 |
Why?
| | Age Factors | 3 | 2013 | 3335 | 0.100 |
Why?
| | Rectal Fistula | 1 | 2013 | 27 | 0.100 |
Why?
| | Quality of Life | 3 | 2024 | 3192 | 0.100 |
Why?
| | Health Plan Implementation | 1 | 2014 | 136 | 0.100 |
Why?
| | Sertoli Cells | 1 | 2013 | 28 | 0.100 |
Why?
| | Reactive Oxygen Species | 1 | 1996 | 621 | 0.100 |
Why?
| | Laparoscopy | 1 | 1997 | 475 | 0.090 |
Why?
| | Drug Administration Schedule | 2 | 2018 | 783 | 0.090 |
Why?
| | Stomach | 1 | 2013 | 109 | 0.090 |
Why?
| | Pigmentation | 1 | 2013 | 53 | 0.090 |
Why?
| | Cholestasis | 1 | 1995 | 219 | 0.090 |
Why?
| | Treatment Outcome | 6 | 2018 | 11695 | 0.090 |
Why?
| | Colon | 2 | 2013 | 305 | 0.090 |
Why?
| | Microvilli | 2 | 2001 | 75 | 0.090 |
Why?
| | Receptors, Virus | 1 | 2011 | 96 | 0.090 |
Why?
| | Age of Onset | 1 | 2013 | 551 | 0.080 |
Why?
| | Food Hypersensitivity | 2 | 2004 | 164 | 0.080 |
Why?
| | Cystic Fibrosis | 2 | 2015 | 1158 | 0.080 |
Why?
| | Health Care Costs | 1 | 2014 | 427 | 0.080 |
Why?
| | Risk Assessment | 2 | 2011 | 3676 | 0.080 |
Why?
| | GTP-Binding Proteins | 2 | 2024 | 153 | 0.080 |
Why?
| | Plant Proteins | 1 | 2011 | 112 | 0.080 |
Why?
| | Age Distribution | 1 | 2011 | 403 | 0.080 |
Why?
| | Sex Distribution | 1 | 2011 | 386 | 0.080 |
Why?
| | Mutation, Missense | 1 | 2011 | 340 | 0.080 |
Why?
| | Statistics, Nonparametric | 2 | 2000 | 427 | 0.080 |
Why?
| | Hospitals, Pediatric | 1 | 2013 | 557 | 0.070 |
Why?
| | Cytomegalovirus Infections | 2 | 2001 | 206 | 0.070 |
Why?
| | Reference Values | 1 | 2011 | 798 | 0.070 |
Why?
| | Prednisolone | 1 | 2009 | 66 | 0.070 |
Why?
| | Diagnosis, Differential | 2 | 2007 | 1495 | 0.070 |
Why?
| | Immunohistochemistry | 2 | 2011 | 1718 | 0.070 |
Why?
| | Practice Guidelines as Topic | 3 | 2023 | 1563 | 0.070 |
Why?
| | Antibodies | 1 | 2011 | 403 | 0.070 |
Why?
| | Family | 1 | 2013 | 679 | 0.070 |
Why?
| | Liver Transplantation | 1 | 1995 | 823 | 0.070 |
Why?
| | Antibodies, Viral | 3 | 2006 | 672 | 0.070 |
Why?
| | Laboratories | 1 | 2009 | 109 | 0.070 |
Why?
| | Anti-Bacterial Agents | 1 | 2018 | 1915 | 0.070 |
Why?
| | Cafe-au-Lait Spots | 1 | 2007 | 3 | 0.070 |
Why?
| | Cost-Benefit Analysis | 2 | 2014 | 636 | 0.060 |
Why?
| | Prognosis | 3 | 2019 | 4293 | 0.060 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2009 | 237 | 0.060 |
Why?
| | Self-Help Groups | 1 | 2007 | 37 | 0.060 |
Why?
| | Sex Factors | 1 | 2013 | 2114 | 0.060 |
Why?
| | Gastrointestinal Microbiome | 1 | 2015 | 771 | 0.060 |
Why?
| | Disease Progression | 1 | 2014 | 2852 | 0.060 |
Why?
| | Cisapride | 1 | 2006 | 5 | 0.060 |
Why?
| | Liver Cirrhosis | 2 | 2015 | 288 | 0.060 |
Why?
| | Adult | 7 | 2019 | 40506 | 0.060 |
Why?
| | Apgar Score | 1 | 2006 | 20 | 0.060 |
Why?
| | Edible Grain | 1 | 2005 | 49 | 0.060 |
Why?
| | Infant, Low Birth Weight | 1 | 2006 | 153 | 0.050 |
Why?
| | Infant, Newborn, Diseases | 1 | 2006 | 113 | 0.050 |
Why?
| | Mycoses | 1 | 2005 | 88 | 0.050 |
Why?
| | Child Nutrition Disorders | 1 | 2004 | 20 | 0.050 |
Why?
| | Societies, Medical | 4 | 2018 | 887 | 0.050 |
Why?
| | Growth | 1 | 2004 | 49 | 0.050 |
Why?
| | Cytoskeletal Proteins | 1 | 2004 | 156 | 0.050 |
Why?
| | Catheterization | 2 | 2001 | 183 | 0.050 |
Why?
| | Adenomatous Polyposis Coli | 2 | 2007 | 40 | 0.050 |
Why?
| | Nutrition Assessment | 1 | 2004 | 92 | 0.050 |
Why?
| | Genetic Testing | 1 | 2007 | 482 | 0.050 |
Why?
| | Peptide Fragments | 1 | 2007 | 699 | 0.050 |
Why?
| | Atrophy | 1 | 2003 | 201 | 0.050 |
Why?
| | Research | 2 | 2004 | 431 | 0.050 |
Why?
| | T-Lymphocytes, Helper-Inducer | 2 | 1993 | 131 | 0.050 |
Why?
| | Trans-Activators | 1 | 2004 | 405 | 0.050 |
Why?
| | Paracentesis | 1 | 2001 | 16 | 0.040 |
Why?
| | Colonic Diseases | 1 | 2001 | 34 | 0.040 |
Why?
| | Patient Compliance | 1 | 2006 | 589 | 0.040 |
Why?
| | Allergy and Immunology | 1 | 2002 | 42 | 0.040 |
Why?
| | Ascites | 1 | 2001 | 49 | 0.040 |
Why?
| | North America | 2 | 2018 | 310 | 0.040 |
Why?
| | Infant, Premature | 1 | 2006 | 611 | 0.040 |
Why?
| | Evidence-Based Medicine | 1 | 2005 | 732 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2005 | 2032 | 0.040 |
Why?
| | Lymphocyte Count | 1 | 2000 | 164 | 0.040 |
Why?
| | Longitudinal Studies | 2 | 2006 | 2947 | 0.040 |
Why?
| | Cohort Studies | 2 | 2003 | 5965 | 0.040 |
Why?
| | Genes, p53 | 1 | 1999 | 67 | 0.040 |
Why?
| | Genes, ras | 1 | 1999 | 96 | 0.040 |
Why?
| | Smoking | 1 | 2006 | 1472 | 0.040 |
Why?
| | T-Lymphocytes | 1 | 2007 | 1982 | 0.030 |
Why?
| | Aneuploidy | 1 | 1999 | 91 | 0.030 |
Why?
| | Epithelial Cells | 1 | 2004 | 1126 | 0.030 |
Why?
| | Hospitals | 1 | 2023 | 732 | 0.030 |
Why?
| | Atmospheric Pressure | 1 | 2017 | 26 | 0.030 |
Why?
| | Placebo Effect | 1 | 1997 | 25 | 0.030 |
Why?
| | Limit of Detection | 1 | 2017 | 97 | 0.030 |
Why?
| | Diet | 1 | 2005 | 1275 | 0.030 |
Why?
| | Glutathione Peroxidase | 1 | 1997 | 39 | 0.030 |
Why?
| | Anemia | 1 | 1999 | 188 | 0.030 |
Why?
| | Receptors, Cannabinoid | 1 | 2017 | 14 | 0.030 |
Why?
| | Vitamin E | 1 | 1997 | 121 | 0.030 |
Why?
| | Hospital Costs | 1 | 1997 | 124 | 0.030 |
Why?
| | Bile Ducts, Extrahepatic | 1 | 1996 | 20 | 0.030 |
Why?
| | Homozygote | 2 | 2011 | 199 | 0.030 |
Why?
| | Biomarkers | 2 | 2009 | 4275 | 0.030 |
Why?
| | Nursing Audit | 1 | 1996 | 4 | 0.030 |
Why?
| | Free Radical Scavengers | 1 | 1996 | 82 | 0.030 |
Why?
| | Pediatric Nursing | 1 | 1996 | 44 | 0.030 |
Why?
| | Models, Nursing | 1 | 1996 | 37 | 0.030 |
Why?
| | Free Radicals | 1 | 1996 | 110 | 0.030 |
Why?
| | Lipid Peroxidation | 1 | 1996 | 160 | 0.030 |
Why?
| | Ascorbic Acid | 1 | 1997 | 180 | 0.030 |
Why?
| | Portoenterostomy, Hepatic | 1 | 1995 | 43 | 0.030 |
Why?
| | Phagocytes | 1 | 1996 | 81 | 0.030 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2017 | 598 | 0.030 |
Why?
| | Body Mass Index | 1 | 2004 | 2438 | 0.030 |
Why?
| | Capsule Endoscopes | 1 | 2015 | 7 | 0.030 |
Why?
| | Glutathione | 1 | 1997 | 375 | 0.030 |
Why?
| | Radioligand Assay | 2 | 2009 | 37 | 0.030 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2015 | 40 | 0.030 |
Why?
| | Disease Management | 1 | 2019 | 647 | 0.030 |
Why?
| | Rats | 1 | 2003 | 5614 | 0.030 |
Why?
| | Biliary Atresia | 1 | 1996 | 158 | 0.030 |
Why?
| | HLA Antigens | 2 | 2006 | 225 | 0.030 |
Why?
| | Permeability | 1 | 2015 | 168 | 0.030 |
Why?
| | Controlled Clinical Trials as Topic | 1 | 2014 | 27 | 0.030 |
Why?
| | Child Health Services | 1 | 2016 | 185 | 0.030 |
Why?
| | Pregnancy | 2 | 2006 | 7191 | 0.030 |
Why?
| | Gene Expression | 1 | 1999 | 1490 | 0.030 |
Why?
| | Nurse Practitioners | 1 | 1996 | 140 | 0.030 |
Why?
| | Digestive System Surgical Procedures | 1 | 2014 | 110 | 0.030 |
Why?
| | Child Nutritional Physiological Phenomena | 2 | 2004 | 106 | 0.020 |
Why?
| | Hospitalization | 1 | 2023 | 2434 | 0.020 |
Why?
| | Adaptation, Psychological | 1 | 1998 | 717 | 0.020 |
Why?
| | Animals | 4 | 2017 | 38109 | 0.020 |
Why?
| | Coxsackie and Adenovirus Receptor-Like Membrane Protein | 1 | 2011 | 8 | 0.020 |
Why?
| | Survival Analysis | 1 | 1995 | 1385 | 0.020 |
Why?
| | Genotype | 1 | 2017 | 1835 | 0.020 |
Why?
| | Cricetulus | 1 | 2011 | 118 | 0.020 |
Why?
| | CHO Cells | 1 | 2011 | 171 | 0.020 |
Why?
| | Vacuoles | 2 | 2001 | 38 | 0.020 |
Why?
| | Cricetinae | 1 | 2011 | 304 | 0.020 |
Why?
| | Heterozygote | 1 | 2011 | 315 | 0.020 |
Why?
| | Morphogenesis | 1 | 2011 | 173 | 0.020 |
Why?
| | Survival Rate | 1 | 1995 | 2092 | 0.020 |
Why?
| | Feasibility Studies | 1 | 2014 | 1095 | 0.020 |
Why?
| | Transfection | 1 | 2011 | 940 | 0.020 |
Why?
| | Thinness | 1 | 2009 | 99 | 0.020 |
Why?
| | Methyltransferases | 1 | 2009 | 74 | 0.020 |
Why?
| | Zebrafish Proteins | 1 | 2011 | 311 | 0.020 |
Why?
| | International Cooperation | 1 | 2009 | 198 | 0.020 |
Why?
| | Biomedical Research | 1 | 2014 | 710 | 0.020 |
Why?
| | Mutation | 1 | 1999 | 4099 | 0.020 |
Why?
| | Zebrafish | 1 | 2011 | 528 | 0.020 |
Why?
| | ROC Curve | 1 | 2009 | 615 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2011 | 906 | 0.020 |
Why?
| | Tuberculosis | 1 | 2009 | 291 | 0.010 |
Why?
| | Pediatrics | 1 | 2014 | 1115 | 0.010 |
Why?
| | Inflammation | 1 | 2017 | 2880 | 0.010 |
Why?
| | Thyroglobulin | 1 | 2005 | 29 | 0.010 |
Why?
| | Iodide Peroxidase | 1 | 2005 | 34 | 0.010 |
Why?
| | Genes, APC | 1 | 2004 | 11 | 0.010 |
Why?
| | Seroepidemiologic Studies | 1 | 2005 | 172 | 0.010 |
Why?
| | Antibody Specificity | 1 | 2005 | 181 | 0.010 |
Why?
| | Adenomatous Polyposis Coli Protein | 1 | 2004 | 20 | 0.010 |
Why?
| | Loss of Heterozygosity | 1 | 2004 | 52 | 0.010 |
Why?
| | Organ Specificity | 1 | 2005 | 313 | 0.010 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2011 | 2147 | 0.010 |
Why?
| | Phenotype | 1 | 2011 | 3164 | 0.010 |
Why?
| | Neutralization Tests | 2 | 1993 | 76 | 0.010 |
Why?
| | beta Catenin | 1 | 2004 | 253 | 0.010 |
Why?
| | Malabsorption Syndromes | 1 | 2002 | 16 | 0.010 |
Why?
| | Transforming Growth Factor beta | 1 | 2004 | 479 | 0.010 |
Why?
| | Plasma Volume | 1 | 2001 | 20 | 0.010 |
Why?
| | Punctures | 1 | 2001 | 40 | 0.010 |
Why?
| | Alleles | 1 | 2004 | 881 | 0.010 |
Why?
| | Gastroschisis | 1 | 2001 | 32 | 0.010 |
Why?
| | Needles | 1 | 2001 | 62 | 0.010 |
Why?
| | Aging | 1 | 1992 | 1966 | 0.010 |
Why?
| | Immunity, Cellular | 2 | 1993 | 272 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2011 | 4569 | 0.010 |
Why?
| | Anastomosis, Surgical | 1 | 2001 | 157 | 0.010 |
Why?
| | Immunoglobulin G | 1 | 2005 | 893 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 2001 | 415 | 0.010 |
Why?
| | Drainage | 1 | 2001 | 185 | 0.010 |
Why?
| | United States | 1 | 2018 | 15988 | 0.010 |
Why?
| | Mice | 1 | 2017 | 18365 | 0.010 |
Why?
| | Family Relations | 1 | 1998 | 88 | 0.010 |
Why?
| | Autoradiography | 1 | 1996 | 65 | 0.010 |
Why?
| | RNA-Directed DNA Polymerase | 1 | 1996 | 35 | 0.010 |
Why?
| | Single-Blind Method | 1 | 1996 | 312 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 1996 | 1054 | 0.010 |
Why?
| | Base Sequence | 1 | 1996 | 2191 | 0.010 |
Why?
| | Immunity, Maternally-Acquired | 1 | 1992 | 19 | 0.010 |
Why?
| | RNA, Viral | 1 | 1996 | 688 | 0.010 |
Why?
| | Antibody Formation | 1 | 1993 | 294 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 1996 | 2931 | 0.010 |
Why?
| | Middle Aged | 2 | 2007 | 35928 | 0.010 |
Why?
| | Acute Disease | 1 | 1993 | 1031 | 0.000 |
Why?
| | Fetal Blood | 1 | 1992 | 342 | 0.000 |
Why?
| | Postoperative Complications | 1 | 2001 | 2920 | 0.000 |
Why?
| | Lymphocyte Activation | 1 | 1992 | 1126 | 0.000 |
Why?
| | Cell Line | 1 | 1993 | 2882 | 0.000 |
Why?
| | HIV Infections | 1 | 2002 | 3154 | 0.000 |
Why?
| | Aged | 1 | 1999 | 25947 | 0.000 |
Why?
|
|
Hoffenberg's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|